Astera Labs, Inc. $ALAB Shares Sold by SteelPeak Wealth LLC

SteelPeak Wealth LLC decreased its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 28.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,283 shares of the company’s stock after selling 1,739 shares during the period. SteelPeak Wealth LLC’s holdings in Astera Labs were worth $469,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Lido Advisors LLC raised its position in Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after acquiring an additional 57 shares during the period. Perigon Wealth Management LLC increased its stake in shares of Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after purchasing an additional 73 shares in the last quarter. Sound Income Strategies LLC raised its position in shares of Astera Labs by 9.2% during the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares during the last quarter. Venturi Wealth Management LLC lifted its stake in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after buying an additional 84 shares in the last quarter. Finally, Goldstein Advisors LLC lifted its position in shares of Astera Labs by 5.8% in the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after acquiring an additional 88 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Morgan Stanley boosted their price target on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Citigroup cut shares of Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Roth Capital reiterated a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Susquehanna raised their price target on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and a consensus price target of $275.75.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $303.62 on Friday. The business’s 50 day moving average price is $349.32 and its 200 day moving average price is $220.59. The company has a market cap of $52.04 billion, a price-to-earnings ratio of 205.15, a PEG ratio of 3.42 and a beta of 3.66. Astera Labs, Inc. has a one year low of $96.79 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period last year, the company earned $0.33 EPS. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts predict that Astera Labs, Inc. will post 1.88 EPS for the current fiscal year.

Insider Activity

In other Astera Labs news, Director Bethany Mayer sold 686 shares of the business’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total value of $270,997.44. Following the transaction, the director directly owned 5,550 shares in the company, valued at $2,192,472. The trade was a 11.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the transaction, the director owned 57,466 shares in the company, valued at $25,859,700. The trade was a 5.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,700,432 shares of company stock valued at $449,062,723 in the last quarter. Insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.